Literature DB >> 1979511

Inhibition of nicotine-induced relaxation of the bovine retractor penis muscle by compounds known to have ganglion-blocking properties.

S Alaranta1, E Klinge, T Pätsi, N O Sjöstrand.   

Abstract

1. The relative potency in blocking the nicotine-induced relaxation of the bovine retractor penis muscle (BRP) was estimated for 12 drugs known to have ganglion-blocking properties. 2. The order of potency of the drugs studied was mecamylamine greater than chlorisondamine greater than pentolinium greater than propantheline greater than (+)-tubocurarine greater than hexamethonium greater than emepronium greater than tetraethylammonium greater than glycopyrrolate greater than decamethonium greater than butylscopolamine greater than scopolamine. 3. The results conform well to those obtained with other pharmacological methods used for the estimation of ganglion-blocking activity. 4. It is concluded that blockade of the nicotinic relaxation of the BRP can be used as an alternative method for quantitative assessment of ganglion-blocking activity. 5. Advantages of this technique are that it discriminates well between antinicotinic and antimuscarinic activity and that it satisfies most or all ethical and economical demands. 6. It is also possible that this method has certain value in predicting whether a drug has enough ganglion-blocking activity to be likely to cause impotence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979511      PMCID: PMC1917696          DOI: 10.1111/j.1476-5381.1990.tb12732.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  The actions of heterocyclic bisquaternary compounds, especially of a pyrrolidinium series.

Authors:  D F MASON; R WIEN
Journal:  Br J Pharmacol Chemother       Date:  1955-03

2.  Ganglionic blockade by a new bisquaternary series, including chlorisondamine dimethochloride.

Authors:  A J PLUMMER; J H TRAPOLD; J A SCHNEIDER; R A MAXWELL; A E EARL
Journal:  J Pharmacol Exp Ther       Date:  1955-10       Impact factor: 4.030

3.  The use of serial carotid occlusion, nictitating membrane and cross-circulation technics in the investigation of the central hypotensive activity of ganglionic blocking agents.

Authors:  H E LAPE; J O HOPPE
Journal:  J Pharmacol Exp Ther       Date:  1956-04       Impact factor: 4.030

4.  Mydriasis in the mouse: a quantitative method of estimating parasympathetic ganglion block.

Authors:  N D EDGE
Journal:  Br J Pharmacol Chemother       Date:  1953-03

5.  Paralysis of autonomic ganglia by methonium salts.

Authors:  W D M PATON; E J ZAIMIS
Journal:  Br J Pharmacol Chemother       Date:  1951-03

6.  Effects of ganglion-blocking substances on the small intestine.

Authors:  W FELDBERG
Journal:  J Physiol       Date:  1951-05       Impact factor: 5.182

7.  Impotence due to Methantheline Bromide.

Authors:  N H SCHWARTZ; B D ROBINSON
Journal:  N Y State J Med       Date:  1952-06-15

8.  Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat.

Authors:  W C Bowman; S N Webb
Journal:  J Pharm Pharmacol       Date:  1972-10       Impact factor: 3.765

9.  Contraction and relaxation of the retractor penis muscle and the penile artery of the bull.

Authors:  E Klinge; N O Sjöstrand
Journal:  Acta Physiol Scand Suppl       Date:  1974

10.  Pharmacological properties of pempidine (1:2:2:6:6-pentamethylpiperidine), a new ganglion-blocking compound.

Authors:  S J CORNE; N D EDGE
Journal:  Br J Pharmacol Chemother       Date:  1958-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.